Catalyst Wire Dossier Catalyst Wire Dossier

Telomelysin

OBP-301
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Telomelysin, covering 2024-06-25 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery [Phase 1]

See pricing